Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

CHONGQING, CHINA - FEBRUARY 3: In this photo illustration, a smartphone displays the logo of Moderna, Inc. (NASDAQ: MRNA), a U.S.-based biotechnology company specializing in messenger RNA (mRNA) ...

BioNTech SE BNTX shares are down during Tuesday’s premarket session as the company announced plans for its co-founders to ...

They aren't just "pandemic stocks." ...

Moderna (MRNA) stock has shed roughly 90% of its value since its 2021 peak. When I wrote about the Moderna stock setup last week, shares sat around $50. Today they’ve nudged back to about $53 — but ...

Shares of Moderna MRNA rose about 4% on Friday after the company announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization to ...

Moderna MRNA announced that it entered a settlement agreement resolving a patent dispute with Genevant Sciences, a subsidiary of Roivant Sciences ROIV, and Arbutus Biopharma ABUS. With this deal, ...

Is IBRX a good stock to buy now? We came across a bullish thesis on ImmunityBio, Inc. on r/pennystocks by Bailey-96. In this ...